These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 6990075

  • 1. Active specific immunotherapy of established micrometastasis: effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs.
    Peters LC, Hanna MG.
    J Natl Cancer Inst; 1980 Jun; 64(6):1521-5. PubMed ID: 6990075
    [Abstract] [Full Text] [Related]

  • 2. Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery.
    Hanna MG, Peters LC.
    Cancer; 1978 Dec; 42(6):2613-25. PubMed ID: 728864
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct; 67(4):863-9. PubMed ID: 6944553
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [Abstract] [Full Text] [Related]

  • 5. Postoperative active-specific immunotherapy of lymph node micrometastasis in a guinea pig tumor model.
    Bier H, Armonat G, Bier J, Schirrmacher V, Ganzer U.
    ORL J Otorhinolaryngol Relat Spec; 1989 Oct; 51(4):197-205. PubMed ID: 2664632
    [Abstract] [Full Text] [Related]

  • 6. Active specific immunotherapy of residual micrometastasis: the acute and chronic inflammatory response in induction of tumor immunity by BCG-tumor cell immunization.
    Hanna MG, Bucana C.
    J Reticuloendothel Soc; 1979 Oct; 26(4):439-51. PubMed ID: 513055
    [No Abstract] [Full Text] [Related]

  • 7. Active specific immunotherapy of established micrometastases with BCG plus tumor cell vaccines: effective treatment of BCG side effects with isoniazid.
    Hanna MG, Pollack VA, Peters LC, Hoover HC.
    Cancer; 1982 Feb 15; 49(4):659-64. PubMed ID: 7055781
    [Abstract] [Full Text] [Related]

  • 8. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG, Peters LC.
    Cancer Res; 1978 Jan 15; 38(1):204-9. PubMed ID: 201374
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E, Peters L, Rapp HJ, Hanna MG, Hunter JT.
    Infect Immun; 1979 May 15; 24(2):565-66. PubMed ID: 378859
    [Abstract] [Full Text] [Related]

  • 10. Effect of isoniazid on BCG-mediated tumor immunity.
    Romolo JL, Loyd B, Cohen MH.
    Surg Forum; 1977 May 15; 28():158-9. PubMed ID: 364713
    [No Abstract] [Full Text] [Related]

  • 11. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T, Tokunaga T, Murohashi T.
    J Natl Cancer Inst; 1977 Mar 15; 58(3):803-8. PubMed ID: 320348
    [Abstract] [Full Text] [Related]

  • 12. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P, Mathews HL.
    Cancer Res; 1980 Sep 15; 40(9):3214-7. PubMed ID: 6159072
    [Abstract] [Full Text] [Related]

  • 13. Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors.
    Peters LC, Brandhorst JS, Hanna MG.
    Cancer Res; 1979 Apr 15; 39(4):1353-60. PubMed ID: 217533
    [No Abstract] [Full Text] [Related]

  • 14. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
    Yarkoni E, Rapp HJ.
    Oncology; 1982 Apr 15; 39(5):314-8. PubMed ID: 7099513
    [Abstract] [Full Text] [Related]

  • 15. Eradication of microscopic hepatic metastases by active specific immunization.
    Sukumar S, Hunter JT, Terata N, Rapp HJ.
    Cancer Immunol Immunother; 1983 Apr 15; 14(3):151-4. PubMed ID: 6340824
    [Abstract] [Full Text] [Related]

  • 16. Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinoma.
    de Jong WH, Teppema JS, Wagenaar SS, Paques M, Steerenberg PA, Ruitenberg EJ.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986 Apr 15; 50(3):249-69. PubMed ID: 2870577
    [Abstract] [Full Text] [Related]

  • 17. Cellular interactions modulating host resistance to tumours.
    Baldwin RW, Byers VS, Hannant D, Jones JA, Pimm MV, Price MR.
    Recent Results Cancer Res; 1982 Apr 15; 80():338-45. PubMed ID: 7036295
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery.
    Ashley MP, Zbar B, Hunter JT, Rapp HJ, Sugimoto T.
    Cancer Res; 1980 Nov 15; 40(11):4197-203. PubMed ID: 7471060
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
    Key ME, Brandhorst JS, Hanna MG.
    J Immunol; 1983 Jun 15; 130(6):2987-92. PubMed ID: 6304194
    [Abstract] [Full Text] [Related]

  • 20. Augmentation of immunity of line 10 hepatoma by BCG: comparison of different BCG preparations.
    Bartlett GL, Kreider JW, Purnell DM, Katsilas DC.
    Cancer; 1980 Aug 01; 46(3):488-96. PubMed ID: 6994867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.